James Kempson

12PUBLICATIONS
36CO-AUTHORS
Biologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)MicrotechnologyPowder and particle technologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 03, 2025
Desymmetrization of <i>meso</i>-Anhydride Enabled Enantioselective Synthesis of (-)-7-(Bromomethylene)-3-amidobicyclo[2.2.1]heptane-2-carboxamide, a Scaffold for Divergent Drug Discovery Synthesis.

Jianqing Li, Subramaniam Krishnananthan, Daniel Smith

|May 24, 2025
Discovery and Characterization of a First-in-Class LIV1-TLR7/8 Immunomodulatory Conjugate with Robust Myeloid Activation and Antitumor Activity.

Sayumi Yamazoe, Yam Poudel, Emanuela Sega

|Apr 25, 2024
Process Development of a Macrocyclic Peptide Inhibitor of PD-L1.

Subha Mukherjee, Amanda Rogers, Gardner Creech

|Apr 23, 2024
Challenges with the Synthesis of a Macrocyclic Thioether Peptide: From Milligram to Multigram Using Solid Phase Peptide Synthesis (SPPS).

James Kempson, Rulin Zhao, Joseph Pawluczyk

|Oct 27, 2021
Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor.

Yong Zhang, Karen E Parrish, David R Tortolani

|Oct 06, 2021
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders.

Huji Turdi, Hannguang Chao, Jon J Hangeland

Pageof 2

Frequent Collaborators

4 joint publications

Xiaoping Hou

4 joint publications

Anuradha Gupta

3 joint publications

Martins S Oderinde

3 joint publications

Antonio Ramirez